Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

United Kingdom News News

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients HKUniversity COVID19 SARSCoV2 Mortality Molnupiravir NirmatrelvirRitonavir

By Dr. Priyom Bose, Ph.D.Oct 12 2022Reviewed by Benedette Cuffari, M.Sc. Since the beginning of the coronavirus disease 2019 pandemic, scientists have worked relentlessly to understand different aspects of the severe acute respiratory syndrome coronavirus 2 .

Based on these findings, non-severe COVID-19 patients with a high risk of hospitalization were treated with these antiviral agents. The standard treatment duration for both molnupiravir and nirmatrelvir-ritonavir is five days, followed by a second course if required. Data were obtained from the Hospital Authority, which manages all public hospitals and clinics in Hong Kong. The clinical outcomes of mild to moderately infected SARS-CoV-2 patients over 60 years who were prescribed molnupiravir and nirmatrelvir-ritonavir were assessed.

An IPTW-adjusted Cox model revealed that mild to moderately infected COVID-19 patients who were at a high risk of complications were associated with a reduced risk of all-cause mortality when prescribed oral antivirals. This was true for both cohorts.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

“I took part in the largest nutrition study in the world – this is what I learned”“I took part in the largest nutrition study in the world – this is what I learned”“I realised that I’m prepared to go quite far to discover the inner workings of my biology when I found myself applying a blood sugar device to my arm on a Sunday morning.”
Read more »

Supreme Court denies appeal of death sentence for Charleston church shooterSupreme Court denies appeal of death sentence for Charleston church shooterThe Supreme Court has denied an appeal from a man contesting his death sentence for the 2015 mass shooting of nine people in a historic black church.
Read more »

This Is Now The Most Common Covid SymptomThis Is Now The Most Common Covid SymptomCases are expected to peak in November, according to the Zoe Health Study app.
Read more »

Association of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort studyAssociation of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort studyIn a population-based cohort study in Scotland, Abiodun Adanikin and colleagues study the association of birthweight centiles and motor, communication, and social developmental concerns identified at ages 2 to 3.5 years of age.
Read more »

A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19 - npj Digital MedicineA method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19 - npj Digital Medicinenpj Digital Medicine - A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19
Read more »



Render Time: 2025-02-15 04:42:15